Canadian startup Encycle Therapeutics nabs C$2.85 mln

By Iris Dorbian — 4 months ago

Toronto-based drug discovery company Encycle Therapeutics has closed C$2.85 million in funding. The investors were Takeda Ventures Inc, Accel-Rx Health Sciences Accelerator, BDC Capital and MaRS Investment Accelerator Fund. Encycle is a University of Toronto spin-out.